Loading...

MLTX - MoonLake Immunotherapeutics

Top Biomed Signal for 01-28-2024
Top Biomed Stock Signal: MLTX


Loading Chart MLTX

Stock Signal Information


Signal

Top Biomed Stock Signal: MLTX
Report Date: 01-28-2024
Symbol: MLTX - MoonLake Immunotherapeutics
Sector:
Industry:
Top Biomed Stock Signal: MLTX

  MLTX Technical Analysis

Company Contact

MoonLake Immunotherapeutics (MLTX)
Dorfstrasse 29
Zug, 6300
Phone:
Website: https://www.moonlaketx.com
CEO:

MLTX, MoonLake Immunotherapeutics

MLTX MoonLake Immunotherapeutics Logo Image

NASDAQ, NASDAQ Global Market


Company Profile

MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or radiographic axial spondyloarthritis. MoonLake Immunotherapeutics was founded in 2021 and is headquartered in Zug, Switzerland.